Latest Distributions News

The week was split between big earnings reactions and small-cap rocks-and-rigs rallies. Pro Medicus sank despite record numbers, while a handful of explorers jumped on fresh discoveries and policy wins.

Takeover chatter lit up Pepper Money, while Identitii ran hard after a regulator stepped in. At the other end, AMP slid despite higher profit, as investors weighed leadership change and legal costs.

Healthcare stocks split into two stories this week: big names sold off hard, while a few small caps ran on clear news. The biggest moves came from a sharp fall in Pro Medicus and Cochlear, while Noxopharm jumped after a top-tier journal publication.

ECP Emerging Growth Limited reported a 6.9% portfolio loss for H1 2025, underperforming the ASX Small Ordinaries Index, yet declared a fully franked interim dividend and teased a significant special dividend.

BTC Health’s investee, BTC Cardio, has landed exclusive Australian distribution rights for Jafron Biomedical’s hemoperfusion cartridges, aiming for a 2026 market debut pending regulatory approval.

WCM Global Growth Limited reported a net operating profit of $22.9 million for H1 FY2026 and announced an increased fully franked interim dividend, reinforcing its progressive dividend policy.

Global Uranium and Enrichment Limited has been fully acquired by Snow Lake Resources through a share and option scheme, leading to GUE's imminent delisting from the ASX.

Advance ZincTek Limited has confirmed a shareholder-approved capital return of 2 cents per share, distributing approximately A$1.252 million back to investors. Payment instructions have been issued ahead of the scheduled February payout.

The CD Private Equity Fund Series reported robust performance in 2025, with improved exit activity and solid distributions despite currency headwinds. The funds continue to focus on asset-by-asset realisations while exploring portfolio liquidity options.

WAM Leaders Limited has announced a fully franked ordinary dividend of 4.8 cents per share for the half-year ending December 2025, with a Dividend Reinvestment Plan available to shareholders.

Osteopore Limited has secured an exclusive three-year distribution deal with Medprin Biotech GmbH to broaden its presence in Latin America's craniofacial reconstruction market, tapping into a region poised for significant growth.

Microequities Asset Management Group Limited has reported a robust half-year performance with a 41% jump in profit after tax and record funds under management reaching $657 million. The company also announced a 21% increase in its fully franked interim dividend.